1. Home
  2. FGEN vs ANEB Comparison

FGEN vs ANEB Comparison

Compare FGEN & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • ANEB
  • Stock Information
  • Founded
  • FGEN 1993
  • ANEB 2020
  • Country
  • FGEN United States
  • ANEB United States
  • Employees
  • FGEN N/A
  • ANEB N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • ANEB Biotechnology: Pharmaceutical Preparations
  • Sector
  • FGEN Health Care
  • ANEB Health Care
  • Exchange
  • FGEN Nasdaq
  • ANEB Nasdaq
  • Market Cap
  • FGEN 34.5M
  • ANEB 36.7M
  • IPO Year
  • FGEN 2014
  • ANEB 2021
  • Fundamental
  • Price
  • FGEN $0.49
  • ANEB $1.54
  • Analyst Decision
  • FGEN
  • ANEB Buy
  • Analyst Count
  • FGEN 0
  • ANEB 1
  • Target Price
  • FGEN N/A
  • ANEB $8.00
  • AVG Volume (30 Days)
  • FGEN 1.0M
  • ANEB 13.3K
  • Earning Date
  • FGEN 02-24-2025
  • ANEB 02-11-2025
  • Dividend Yield
  • FGEN N/A
  • ANEB N/A
  • EPS Growth
  • FGEN N/A
  • ANEB N/A
  • EPS
  • FGEN N/A
  • ANEB N/A
  • Revenue
  • FGEN $180,015,000.00
  • ANEB N/A
  • Revenue This Year
  • FGEN $21.91
  • ANEB N/A
  • Revenue Next Year
  • FGEN N/A
  • ANEB N/A
  • P/E Ratio
  • FGEN N/A
  • ANEB N/A
  • Revenue Growth
  • FGEN 16.15
  • ANEB N/A
  • 52 Week Low
  • FGEN $0.18
  • ANEB $0.80
  • 52 Week High
  • FGEN $2.93
  • ANEB $3.30
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 41.45
  • ANEB 52.82
  • Support Level
  • FGEN $0.45
  • ANEB $1.39
  • Resistance Level
  • FGEN $0.51
  • ANEB $1.70
  • Average True Range (ATR)
  • FGEN 0.04
  • ANEB 0.13
  • MACD
  • FGEN -0.01
  • ANEB -0.00
  • Stochastic Oscillator
  • FGEN 3.25
  • ANEB 60.00

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.

Share on Social Networks: